GlassScriptPhysician profile
Roopal Arun Patel
NPI 1609892538
$969.63
in general payments reported to CMS, 2019-2025
16 companies · $295 in 2025
The $295 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $164 · 2020: $27.42 · 2022: $162 · 2023: $81.30 · 2024: $241 · 2025: $295.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $617.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $246.31 | 2022-2025 | Azstarys |
| Collegium Pharmaceutical, INC. | $102.56 | 2025 | Jornay Pm |
| Pfizer INC. | $93.52 | 2022-2024 | |
| Merck Sharp & Dohme LLC | $92.89 | 2019-2025 | Gardasil 9, Gardasil, Vaxelis |
| Ironshore Pharmaceuticals INC. | $86.30 | 2019-2024 | |
| Cranial Technologies, INC | $71.64 | 2019-2023 | Doc Band |
| Glaxosmithkline, LLC. | $69.26 | 2019-2024 | Bexsero |
| Noven Therapeutics, LLC | $48.16 | 2024-2025 | Xelstrym |
| Neos Therapeutics, LP | $29.93 | 2019-2025 | Cotempla Xr-Odt |
| Verrica Pharmaceuticals INC. | $22.37 | 2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $20.88 | 2024 | |
| Phadia US INC. | $18.88 | 2023 | Immunocap |
| Vertical Pharmaceuticals, LLC | $18.45 | 2019 | |
| Kaleo, INC. | $17.64 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.66 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.18 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roopal Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.